EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis

Kaixiang Zhong, Haiming Chen, Peng Hou, Linling Cheng, Wenliang Guo, Youcai Li, Jie Lv, Miao Ke, Xiaofeng Wu, Yongxia Lei, Chunli Liu, Cheng Hong und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-024-06986-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Kaixiang Zhong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, 510010, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Systemic Vasculitis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: the Ministry of Industry and Information Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The role of fibroblast activation protein (FAP)-targeted imaging in systemic vasculitis is currently unclear. We aimed to evaluate the clinical value of fluorine-18-labeled FAP inhibitor 42 ([18F]FAPI-42) in patients with systemic vasculitis and to compare with [18F]fluorodeoxyglucose (FDG) imaging. METHODS: Patients with systemic vasculitis who underwent dual-tracer PET/CT([18F]FDG and [18F]FAPI) imaging from September 2020 to March 2022 were retrospectively analyzed. Positive lesions are defined as vascular/extravascular lesions with increased tracer uptake above surrounding background, which cannot be attributed to the physiologic biodistribution of the radiotracer. The vascular/extravascular lesion detection rate and semiquantitative values (SUVmax, TBRblood and TBRliver) of [18F]FAPI and [18F]FDG were compared, and the correlation between the extent and range of tracer uptake and levels of inflammatory markers was investigated. RESULTS: Thirty patients (13 males and 17 females; mean age, 52.5 ± 17.2 years) with systemic vasculitis were included (17 large vessel vasculitis, 10 anti-neutrophil cytoplasmic antibody-associated vasculitis, 2 Behcet's disease and 1 polyarteritis nodosa). [18F]FDG PET/CT had positive findings in 93.3% (28/30) of patients, while [18F]FAPI PET/CT had positive findings in all patients (100%, P = 0.500). Compared with [18F]FDG PET/CT, [18F]FAPI PET/CT detected more lesions (161/168 vs. 145/168, P = 0.005), and more extensive vascular involvement in 60% (18/30) of patients. Although SUVmax did not differ significantly between [18F]FAPI and [18F]FDG (median, 5.94 vs. 5.46, P = 0.517), [18F]FAPI had higher TBRliver (median, 9.59 vs. 3.15, P < 0.001) and TBRblood (median, 5.45 vs. 4.20, P = 0.006). The total number of positive lesions in FAPI PET/CT show a moderate correlation with erythrocyte sedimentation rate (rs =0.478, P = 0.008) and C-reactive protein (rs =0.486, P = 0.006). After treatment, follow-up FAPI PET/CT of 6 patients showed decreased SUVmax, TBR and number of detected lesions, paralleling the clinical remission. CONCLUSION: [18F]FAPI PET/CT imaging is a promising imaging modality for the diagnosis and therapeutic monitoring of systemic vasculitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Systemic VasculitisHumansFemaleMaleMiddle AgedAdultRetrospective StudiesAgedRadiopharmaceuticalsMembrane ProteinsEndopeptidasesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

Fibroblast activation proteinFibroblast activation protein inhibitorPositron emission tomographySystemic vasculitis

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsMembrane ProteinsEndopeptidasesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, 510010, China.
  • State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanj…
  • Department of Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, 510010, China. 71lu@163.com.

ORCID-Profile: Xinlu Wang

Förderung

  • the Ministry of Industry and Information Technology

Zitieren

APA

Zhong, K., Chen, H., Hou, P., Cheng, L., Guo, W., Li, Y., Lv, J., Ke, M., Wu, X., Lei, Y., Liu, C., Hong, C., & Wang, X. (2025). Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06986-2

Vancouver

Zhong K, Chen H, Hou P, Cheng L, Guo W, Li Y, et al. Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06986-2

BibTeX
@article{Zhong2025,
  author = {Zhong, Kaixiang and Chen, Haiming and Hou, Peng and Cheng, Linling and Guo, Wenliang and Li, Youcai and Lv, Jie and Ke, Miao and Wu, Xiaofeng and Lei, Yongxia and Liu, Chunli and Hong, Cheng and Wang, Xinlu},
  title = {Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-024-06986-2}
}
Kostenlos starten →